JNJ
Johnson & Johnson
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 3
Sell signal 2
Dividend Aristocrat
High Gross Profit Margin
Net Income Surges
EPS Below Expectations
Revenue Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About JNJ
Johnson & Johnson
The world's largest, most diversified healthcare products company
One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933
R & D, manufacture and sale of healthcare products
Johnson & Johnson was incorporated in New Jersey in 1887. Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacturing and sales of various products in the healthcare field. Johnson & Johnson is a holding company with operating companies in almost all countries around the world. The company's main focus is on products related to human health and well-being. The company is divided into two business divisions: innovative medicine and medical technology.
Company Financials
EPS
JNJ has released its 2025 Q1 earnings. EPS was reported at 2.77, versus the expected 2.58, beating expectations. The chart below visualizes how JNJ has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
JNJ has released its 2025 Q1 earnings report, with revenue of 21.89B, reflecting a YoY change of 2.39%, and net profit of 11.00B, showing a YoY change of 237.91%. The Sankey diagram below clearly presents JNJ’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
